Global MedTech Media InstituteSwitzerlandProfessional healthcare technology intelligence
Editor's Pick · Global
Capital Perspective: William Blair's Recent Transactions and Coverage Dynamics Reflect the Investment Enthusiasm in Medical Technology Innovation
William Blair recently completed advisory services for NavVis's $85 million Series D financing and initiated research coverage on SK hynix and Rapport Therapeutics. These moves reflect the capital activity in the medical technology and biotech innovation sectors, as well as investment banks' focus on cutting-edge technology tracks.
AI applications in healthcare are accelerating their deployment, spanning from imaging diagnostics and pathology analysis to treatment response prediction and remote monitoring, with continuously improving technical performance. However, obstacles such as data quality, interoperability, clinical trust, and regulation are limiting large-scale adoption. Based on industry research, this article analyzes the current applications and key challenges of medical AI, and looks ahead to the transformation direction over the next 3-5 years, from algorithm innovation to system integration.
The medical IT market is projected to reach $502.9 billion by 2035, with telehealth, cloud solutions, and AI technology serving as the primary growth engines. The North American market leads with a 45% share, and data security and interoperability have become the focal points of industry competition.
According to a Market Research Future report, the global wearable medical device market was valued at $44.5 billion in 2025 and is expected to grow to $167.8 billion by 2035, with a CAGR of 14.2%. Expanded CMS reimbursement, the EU digital health strategy, and advances in micro-biosensors are key drivers. North America dominates, while Asia-Pacific is the fastest-growing region. The article analyzes market drivers, challenges, and future trends.
AnalysisCMSMedical technology
Trending topics
Normalized tags help readers follow technology, disease areas, regulatory bodies and markets.
Regulatory Watch
Compliance changes by market
Track AI, device, reimbursement and privacy rules across major regions.
US FDA guidance
EU MDR updates
MENA tenders
AI & Data
Clinical data meets operations
Reporting on AI in diagnostics, imaging, hospital administration and drug research.
Model validation
Data governance
Workflow adoption
Devices & Wearables
Hardware with service economics
Coverage of connected devices, smart diagnostics and the global hardware market.
Remote monitoring
Robotics
Procurement
Biotech Pipeline
Life science innovation signals
Follow genomics, biopharma and precision medicine from research to market.
Genetic testing
Clinical evidence
Companion diagnostics
Market Moves
Companies, capital and partnerships
Concise context for founders, investors, BD teams and analysts.
Funding
M&A
Hospital partnerships
Countries
Global coverage with local context
Follow developments across Global, US, EU, China, MENA, LATAM and APAC.
Country tags
Regional policy
Market entry
Search by the way MedTech teams think
Filter by keyword, country, technology, disease area and publication time.
The global healthcare IT market is growing rapidly. According to the latest industry report, the market size is expected to grow from $246.17 billion in 2024 to $502.91 billion by 2035, with a compound annual growth rate of 6.71%. This article provides an in-depth analysis of key trends such as telemedicine, data interoperability, and cybersecurity, while focusing on regional market landscapes and major company developments, offering forward-looking industry insights for healthcare technology professionals.
The digital health market is expected to grow from $287.8 billion in 2024 to $2.19 trillion by 2034, with a compound annual growth rate of 22.5%. North America leads with a 38.4% share, while Asia-Pacific is the fastest-growing region. Technological innovations such as AI, telemedicine, and wearable devices are reshaping the healthcare industry landscape. This article provides an in-depth analysis of market trends, regional dynamics, and future opportunities.
The U.S. FDA has announced that Dexcom is the first participant in its TEMPO Digital Health Pilot Program, which allows certain digital health devices to be exempt from premarket review while collecting real-world data through Medicare. Dexcom plans to use AI and continuous glucose monitoring technology to screen for prediabetes and type 2 diabetes, marking a deep integration of regulatory innovation and payment reform.
Heidi Health's "Pressure Points 2026" report shows that 83% of clinicians have already adopted ambient AI documentation tools on their own before their institutions establish formal AI governance frameworks, in response to the growing burden of medical documentation.
A joint survey by the American Medical Association (AMA) and Medscape shows that 97% of physicians at least occasionally review patient wearable device data, but fewer than 6% integrate it into clinical workflows. The lack of payment pathways, insufficient electronic health record integration, and concerns about legal liability and reliability are key barriers.